CasNo.366789-02-8,Rivaroxaban,(366789-02-8) Suppliers

1 Gram	Negotiable

Min.Order :1 Gram
Purity: As COA
Payment Terms : L/C,T/T,,MoneyGram,Other

Keywords

Rivaroxaban Manufacturer (S)-Rivaroxaban Supply Rivaroxaban

Quick Details

Appearance:White powder
Application:Used as an anticholelithogenic.
PackAge:1KG/Bag or Bottle,25KG per Box or Drum ,180KG,204KG Drum or Customized
ProductionCapacity:10|Metric Ton|Quarter
Storage:Keep sealed when not in use .
Transportation:By DHL /Fedex /TNT /EMS /Air /Sea etc.

Superiority:

Shanghai Siwei Chemical Co., Ltd is located in Shanghai,China .Our main business is Pharmaceutical Intermediates ,OLED Intermediates ,Food Additives ,Nano Materials ,Rare Earth Materials etc.

We have professional customer service 24H online answer your questions .Cheap price with best quality is our

Have long-term and stable cooperation with major factories and unicersities can provide the best quality with cheap price .

Welcome your inquires ,we are always on your side .

Details:

Rivaroxaban Basic information

Product Name:   Rivaroxaban
Synonyms:   (S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939;Rivaroxaban Isomer;Rivaroxaban;5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
CAS:   366789-02-8
MF:   C19H18ClN3O5S
MW:   435.88
EINECS:   685-132-2

Rivaroxaban Chemical Properties

Melting point    228-229°C
Boiling point    732.6±60.0 °C(Predicted)
density    1.460±0.06 g/cm3(Predicted)
storage temp.    Refrigerator
pka   13.36±0.46(Predicted)

Rivaroxaban Usage And Synthesis

Uses Rivaroxaban is recommended as an option for treating pulmonary embolism and preventing recurrent deep vein thrombosis and pulmonary embolism in adults.
Rivaroxaban (Xarelto, Bayer) is indicated for the 'treatment of deep vein thrombosis and pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism in adults'. For the initial treatment of acute pulmonary embolism, the recommended dosage of rivaroxaban is 15 mg twice daily for the first 21 days followed by 20 mg once daily for continued treatment and prevention of recurrent venous thromboembolism.
Non-Valvular Atrial Fibrillation (NVAF)* to prevent stroke & systemic embolism.
Acute VTE treatment & prevention of recurrent VTE [for deep vein thrombosis (DVT) and pulmonary embolism (PE)].
Prevention of venous thromboembolic events (VTE) in elective total hip or knee replacement surgery (THR, TKR).